These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1903212)

  • 1. Elastolytic activity of human monocytes from synovial fluid and blood of patients with arthritis. Relations to levels of interleukin 6 and soluble interleukin 2 receptor.
    Jensen HS; Tvede N; Diamant M; Mogensen HH; Hansen MB; Thomsen BS; Pedersen PB; Bendtzen K
    Scand J Rheumatol; 1991; 20(2):83-90. PubMed ID: 1903212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies.
    Usón J; Balsa A; Pascual-Salcedo D; Cabezas JA; Gonzalez-Tarrio JM; Martín-Mola E; Fontan G
    J Rheumatol; 1997 Nov; 24(11):2069-75. PubMed ID: 9375862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-2 receptor: elevated levels in serum and synovial fluid of patients with rheumatoid arthritis.
    Carpenter AB; Eisenbeis CH; Carrabis S; Brown MC; Ip SH
    J Clin Lab Anal; 1990; 4(2):130-4. PubMed ID: 2313471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis.
    Horiuchi T; Yoshida T; Koshihara Y; Sakamoto H; Kanai H; Yamamoto S; Ito H
    Endocr J; 1999 Oct; 46(5):643-9. PubMed ID: 10670749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of cytokine receptors sTNF-R55, sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid.
    Partsch G; Wagner E; Leeb BF; Dunky A; Steiner G; Smolen JS
    J Rheumatol; 1998 Jan; 25(1):105-10. PubMed ID: 9458212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arthritic and non-arthritic synovial fluids modulate IL10 and IL1RA gene expression in differentially activated primary human monocytes.
    Lopa S; Leijs MJ; Moretti M; Lubberts E; van Osch GJ; Bastiaansen-Jenniskens YM
    Osteoarthritis Cartilage; 2015 Nov; 23(11):1853-7. PubMed ID: 26521731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.
    Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik JP; Cylwik B; Skowronski J; Chwiecko J
    Clin Exp Rheumatol; 2003; 21(1):63-9. PubMed ID: 12673891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
    Matsumoto T; Iwasaki K
    Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional studies of soluble low-affinity interleukin-2 receptors in rheumatoid synovial fluid.
    Miossec P; Elhamiani M; Edmonds-Alt X; Sany J; Hirn M
    Arthritis Rheum; 1990 Nov; 33(11):1688-94. PubMed ID: 2242065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition.
    Symons JA; Wood NC; Di Giovine FS; Duff GW
    J Immunol; 1988 Oct; 141(8):2612-8. PubMed ID: 3262665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.
    Carotti M; Salaffi F; Ferraccioli GF; Binci MC; Sartini A; Cervini C
    Rheumatol Int; 1994; 14(2):47-52. PubMed ID: 7824835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin 2 and interleukin 2 inhibitors in human serum and synovial fluid. II. Mitogenic stimulation, interleukin 2 production and interleukin 2 receptor expression in rheumatoid arthritis, psoriatic arthritis and Reiter's syndrome.
    Smith MD; Roberts-Thomson PJ
    J Rheumatol; 1989 Jul; 16(7):897-903. PubMed ID: 2788742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated concentrations of monocyte derived cytokines in synovial fluid of children with enthesitis related arthritis and polyarticular types of juvenile idiopathic arthritis.
    Saxena N; Aggarwal A; Misra R
    J Rheumatol; 2005 Jul; 32(7):1349-53. PubMed ID: 15996076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 in synovial fluids, plasma and supernatants from cultured cells of patients with rheumatoid arthritis and other inflammatory arthritides.
    Hovdenes J; Kvien TK; Hovdenes AB
    Scand J Rheumatol; 1990; 19(3):177-82. PubMed ID: 2359995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated expression of interleukin-7 receptor in inflamed joints mediates interleukin-7-induced immune activation in rheumatoid arthritis.
    Hartgring SA; van Roon JA; Wenting-van Wijk M; Jacobs KM; Jahangier ZN; Willis CR; Bijlsma JW; Lafeber FP
    Arthritis Rheum; 2009 Sep; 60(9):2595-605. PubMed ID: 19714586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.
    Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M
    Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated soluble interleukin-2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis.
    Keystone EC; Snow KM; Bombardier C; Chang CH; Nelson DL; Rubin LA
    Arthritis Rheum; 1988 Jul; 31(7):844-9. PubMed ID: 3134896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High levels of interleukin 13 in rheumatoid arthritis sera are modulated by tumor necrosis factor antagonist therapy: association with dendritic cell growth activity.
    Tokayer A; Carsons SE; Chokshi B; Santiago-Schwarz F
    J Rheumatol; 2002 Mar; 29(3):454-61. PubMed ID: 11908556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes.
    De Benedetti F; Pignatti P; Bernasconi S; Gerloni V; Matsushima K; Caporali R; Montecucco CM; Sozzani S; Fantini F; Martini A
    J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.